A higher-value business,
hiding in a cyclical story.
My pitch examines whether the market is overlooking Photronics' shift toward higher-end integrated circuit photomasks, mistaking deferred demand and expansion spending for structural weakness.
Figures from the Fall 2026 pitch; not live prices or realized returns.
Inside the thesis
The opportunity
A transition to higher-value photomasks, a recovery in delayed customer design releases, and capacity investment in Texas and Korea could support stronger earnings power.
Valuation approach
The pitch applies a 19.0× forward P/E to a stated $2.04 forward EPS, versus a reference multiple of 13.3×. The original paper contains the peer comparison and rerating argument.
What could go wrong
Geographic and trade exposure, headline risk from litigation, and the possibility that major foundries retain photomask production in-house could challenge the thesis.